Alzheimer’s disease (AD) remains a major cause of morbidity and mortality worldwide, and
despite extensive research, only a few drugs are available for management of the disease. …

… Alzheimer's disease is a neurodegenerative disease that … -β protein plaques in neurons and
hyperphosphorylation of … in long-term depression in the prefrontal cortex and the potential for …

… of the prefrontal cortex and parietal association areas display the … of neuronal precursors
supplying neurons to expanding … [91], activation of M1 and M3 muscarinic AChR suppresses the …

… loss of neurons positive for the nicotinic monoclonal antibody WF6 in the human frontal cortex
… , A., Human cortical neurons contain both nicotinic and muscarinic acetylcholine receptors: …

… The initial stage involves the accumulation of granular tau oligomers in the frontal cortex, …
and muscarinic acetylcholine receptors due to marked degeneration of cholinergic neurons …

… The primary neuropathology of Alzheimer’s disease is … neurons, mostly affecting the
temporoparietal and frontal … of age-related loss of muscarinic cholinoceptors and adrenoceptors, …

… (or non-specific neuronal depolarization), … Alzheimer's disease. (A) Levels of MMP-3 mRNA,
(B) proMMP-3 and (C) MMP-3 protein were assessed in dorsolateral/medial prefrontal cortex …

… neurons are also present in the medial prefrontal cortex (PFC… nicotinic receptors and muscarinic
M1 receptors induces LTP of … of thalamic neurons caused by the cholinoreceptor agonist …

… , and possibly, Alzheimer’s disease (AD). Here, we explore the physiological and molecular
mechanisms involved in the alterations of the heart neuronal network observed both in …

… both hippocampal and prefrontal cortex-dependent forms … muscarinic receptors in the
modulation of neuronal activity and release of neurotransmitter in various brain regions. Muscarinic …